Deferred Income Tax Liabilities, Net in USD of GILEAD SCIENCES, INC. from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
Gilead Sciences, Inc. quarterly Deferred Income Tax Liabilities, Net history and change rate from Q4 2020 to Q3 2025.
  • Gilead Sciences, Inc. Deferred Income Tax Liabilities, Net for the quarter ending September 30, 2025 was $597M, a 24.8% decline year-over-year.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Change (%)

GILEAD SCIENCES, INC. Quarterly Deferred Income Tax Liabilities, Net (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $597M -$197M -24.8% Sep 30, 2025 10-Q 2025-11-07
Q2 2025 $652M -$255M -28.1% Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $709M -$224M -24% Mar 31, 2025 10-Q 2025-05-07
Q4 2024 $724M -$864M -54.4% Dec 31, 2024 10-Q 2025-11-07
Q3 2024 $794M -$1.19B -60% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $907M -$1.2B -56.9% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $933M -$1.47B -61.1% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1.59B -$1.09B -40.6% Dec 31, 2023 10-K 2025-02-28
Q3 2023 $1.98B -$1.05B -34.7% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $2.11B -$1.26B -37.4% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $2.4B -$1.29B -34.9% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $2.67B -$1.68B -38.6% Dec 31, 2022 10-K 2024-02-23
Q3 2022 $3.04B -$1.57B -34% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $3.36B -$1.01B -23.1% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $3.69B -$777M -17.4% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $4.36B +$442M +11.3% Dec 31, 2021 10-K 2023-02-22
Q3 2021 $4.6B Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $4.37B Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $4.46B Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $3.91B Dec 31, 2020 10-K 2022-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.